Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Mallinckrodt plc is a global specialty pharmaceutical company focused on developing, manufacturing, and marketing branded and generic products for underserved patients with severe conditions. Its core segments include Specialty Brands, offering innovative therapies for autoimmune and rare diseases, and Specialty Generics, producing controlled substances and APIs. The company emphasizes innovation, regulatory compliance, and strategic transactions to expand its portfolio and market presence.
This description was generated via AI from an annual report. Updated about 1 year ago.